AI System Screened for Diabetes Using Vocal Patterns

Researchers developed a tool that detects type 2 diabetes by analyzing vocal changes from short audio recordings.

Updated on Sept. 28, 2026 in Diabetes

A high-quality condenser microphone on an adjustable stand sits in a modern, minimalist studio room with acoustic panels.
Researchers from thymia and RMIT University have developed an AI model that identifies type 2 diabetes by analyzing specific vocal patterns during short audio recordings. AI Illustration. Upload story photo >

Live Poll

Would you trust an AI tool to help screen for your potential health conditions?

Engineers from thymia and RMIT University have created an artificial intelligence model capable of identifying type 2 diabetes through vocal analysis. The system successfully flagged 80 percent of UK study participants who reported living with the condition.

Why it matters

This technology aims to reach undiagnosed individuals who do not undergo routine health screenings, potentially expanding early detection beyond traditional blood testing. It offers a non-invasive alternative for identifying risk using simple audio samples.

The model was trained on 63,000 voice recordings from 21,000 subjects in the UK and US. A sub-group analysis of 801 participants showed a 75 percent accuracy rate when compared against results from home blood tests.

The players

thymia

This health technology company specializes in developing AI-driven tools for diagnostic screening.

RMIT University

Based in Melbourne, Australia, this public research university led the development of the vocal analysis tool.

The details

The AI analyzes 20-second clips of individuals reading Aesop's fables, specifically looking for indicators like raspy speech and reduced respiratory control. Data can be collected via standard phone calls or mobile applications.

Timeline

  1. September 28, 2026: The research findings were published.

Health Landscape

This development represents a departure from standard blood-test diagnostic protocols for individuals aged 40 to 74 by enabling remote screening via voice. It reflects a broader shift toward integrating passive, non-invasive digital biomarkers into early-stage diagnostic pipelines.

This technology could eventually allow individuals to screen for diabetes from home using only a phone call or mobile app. It may reduce the barrier to entry for those currently avoiding traditional clinical blood tests.

The takeaway

Vocal analysis presents a scalable, non-invasive method for identifying health risks before symptoms become severe. Future clinical integration could significantly increase the number of people screened for chronic conditions in non-traditional settings.

Further reading

For additional context on screening technologies, visit the Diabetes section.

Live Poll

Would you trust an AI tool to help screen for your potential health conditions?